Pyxis Oncology, Inc. (PYXS) quarterly cash flow statement — complete operating, investing & financing history
| Cash from Operations | -26M | -10.43M | -13.28M | -17.26M | -22.54M | -19.29M | -14.66M | -3.01M | -20.71M | -15.25M | -17.58M | -11.03M |
| Operating CF Margin % | - | -94.46% | - | -612.16% | - | - | - | - | -128.27% | - | - | - |
| Operating CF Growth % | -15.38% | 45.95% | 9.46% | -474.09% | -8.81% | -26.46% | 16.6% | 72.74% | 22.84% | 12.27% | 14.47% | 53.48% |
| Net Income | -23.27M | -18.11M | -22M | -18.35M | -21.16M | -35.57M | -21.2M | -17.3M | -3.26M | -15.6M | -23.05M | -15.9M |
| Depreciation & Amortization | 459K | 2.9M | 527K | 535K | 552K | 550K | 731K | 585K | 1.12M | 690K | 523K | 524K |
| Stock-Based Compensation | 0 | 2.08M | 3.07M | 3.02M | 3.63M | 2.77M | 2.98M | 2.87M | 4.32M | 3.21M | 5.18M | 3.67M |
| Deferred Taxes | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -1.26M |
| Other Non-Cash Items | 1.2M | -156K | -322K | -694K | -964K | 19.62M | -1.47M | -1.47M | -1.12M | -1.25M | -1.33M | 175K |
| Working Capital Changes | -4.39M | 2.86M | 5.45M | -1.76M | -4.6M | -6.66M | 4.3M | 12.3M | -21.77M | -2.31M | 1.09M | 1.76M |
| Change in Receivables | 0 | 0 | 0 | -3M | 0 | 0 | 0 | 8M | -8M | 0 | 0 | 0 |
| Change in Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Payables | -5.9M | 1.13M | 344K | 6.57M | -2.01M | -10K | -602K | 3.18M | -1.36M | 350K | -1.54M | -1.56M |
| Cash from Investing | 16.37M | 16.26M | 11.47M | 15.3M | 15.82M | 26.66M | -8K | 4K | -18.5M | 10.23M | 6.57M | -22.25M |
| Capital Expenditures | 0 | 0 | -9K | 0 | 0 | 0 | 0 | 0 | -237K | 0 | -61K | -2.26M |
| CapEx % of Revenue | - | - | - | - | - | - | - | - | 1.47% | - | - | - |
| Acquisitions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1K | 0 | -15.19M |
| Investments | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | 0 | -107.31M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 6.66M | 15.19M |
| Cash from Financing | -25K | 669K | -8K | -67K | 0 | 50K | 1.66M | 110K | 57.51M | -25K | -171K | 6.13M |
| Debt Issued (Net) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Equity Issued (Net) | 0 | 740K | 0 | -67K | 2K | 0 | 1.48M | 105K | 57.46M | 0 | 0 | 6.12M |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | 0 | -67K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing | -25K | -71K | -8K | 0 | -2K | 50K | 176K | 5K | 49K | -25K | -171K | 3K |
| Net Change in Cash | -9.66M | 6.5M | -1.81M | -2.03M | -6.71M | 7.42M | -13.02M | -2.89M | 18.3M | -5.05M | -11.18M | -27.16M |
| Free Cash Flow | -26M | -10.43M | -13.29M | -17.26M | -22.54M | -19.29M | -14.66M | -3.01M | -20.95M | -15.25M | -17.64M | -13.29M |
| FCF Margin % | - | -94.46% | - | -612.16% | - | - | - | - | -129.73% | - | - | - |
| FCF Growth % | -15.38% | 45.95% | 9.4% | -474.09% | -7.58% | -26.46% | 16.88% | 77.37% | 32.96% | 20.74% | 28.92% | 44.26% |
| FCF per Share | -0.41 | -0.17 | -0.21 | -0.28 | -0.37 | -0.32 | -0.24 | -0.05 | -0.41 | -0.34 | -0.43 | -0.35 |
| FCF Conversion (FCF/Net Income) | 1.12x | 0.58x | 0.60x | 0.94x | 1.07x | 0.54x | 0.69x | 0.17x | 6.36x | 0.98x | 0.76x | 0.69x |
| Interest Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 28K |